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Introduction
Celiac disease, a gluten-dependent enteropathy, is a 
chronic, systemic autoimmune disorder. Onset, at any 
age in genetically prone subjects, is triggered by glu-
ten-containing foods, such as wheat, barley, rye and 
oatmeal [1, 2]. 
Research into the genetics of celiac disease started in the 
1980s, and in 1984-89, the HLA-DQW2 and HLA-DQ8 
haplotypes were identified as playing a role in predis-
posing to disease onset. Specific types of autoantibod-
ies were found in patients with celiac disease between 
1983 and 1984, and the discovery of the anti-gliadin 
antibody (AGA) and anti-endomysium antibody (EMA) 
confirmed that celiac disease was, mechanistically, an 
autoimmune condition [3]. Celiac disease was proposed 
as a model for elucidating autoimmune diseases when 
recent studies hypothesized that, as in most autoimmune 
disorders, three factors acted synergistically [4, 5], 
namely, genetic predisposition, dietary gluten consump-
tion (the environmental trigger), and an abnormally in-
creased intestinal permeability. 
Celiac disease presents classically as a malabsorption 
syndrome, atypically with a late onset (which is asso-
ciated with nonspecific and even extra-intestinal signs 
and/or symptoms that cannot otherwise be accounted 
for), silently in symptom-free patients who escape be-
ing diagnosed, and potentially in individuals with serum 
positivity but no intestinal lesions [5]. 
Serum screening programmes, greater awareness, and 
improved knowledge of pathogenesis have now led to 
the detection of celiac disease in subjects with only few, 
or only extra-intestinal, symptoms. Prevalence is similar 
in Europe and in countries such as the USA, the Mid-
dle East, North Africa and Central and South America, 
where, until the 1990s, it was considered rare [6, 7]. In 
the 1950s-60s, the prevalence of celiac disease was es-
timated at 1:4000–8000 worldwide; in the 1970s preva-
lence estimates stabilized around 1:450-500, rising to 
1:150-200 in the 1990s. 
In Italy, the prevalence of celiac disease is estimated 
to be 1/100 in adults and children [8]. According to the 
2009 annual report to the regional government, Umbria 
has 1,494 inhabitants with celiac disease (420 males and 
1,074 females). The present report used some epidemio-
logical parameters to profile celiac disease in the prov-
ince of Terni. 
Materials and methods
In accordance with current Italian legislation protecting 
personal information, data on patients with celiac dis-
ease from 2002 to 2010 are provided under anonymous 
format by the Terni Province Health Board No 4, in Um-
bria, Italy. Health Board No 4 covers the province of 
Terni except for the San Venanzo area. Data were ex-
trapolated from the list of individuals with prescription 
charge exemptions for specific medical treatment.
The data included only gender, date of birth and year of 
diagnosis for each patient. Age at onset could thus be 
calculated on a case-by-case basis. 
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Summary
The present work is an epidemiology survey of celiac disease in the 
province of Terni (Umbria, Italy) in 2002–2010. Data were col-
lected from the Local Health Unit (LHU) 4 (ASL 4), Terni database 
and were extrapolated from the overall population of 232,540 (as 
of 2010) by identifying residents with prescription charge exemp-
tions for celiac disease-oriented drugs. Prevalence and incidence 
analysis over the timeframe being examined showed that prevalence 
(330 cases in 2010) has consistently been increasing from 2002 to 
2010, whereas incidence has remained essentially the same with 
minor, yearly fluctuations. Both prevalence and incidence were 
higher in females than in males. Most patients were diagnosed as 
young adults, with the highest rates in the 10-14, 35-40 and 55-60 
age groups. Thus, in the area of investigation, there is evidence for 
consistent delayed diagnosis, raising the possibility that the atypi-
cal form the disease, more difficult to recognize and more likely to 
escape early diagnosis, may have become increasingly commoner 
over time. Because the current prevalence of the disease in the Terni 
area is estimated to approximate 1%, the anticipated number of 
cases should amount to 2,325, which value contrasts with the cur-
rently reported 330 diagnoses. It is suggested that the current illness-
defining criteria should be revised so to implement early diagnosis 
and improve the patients’ quality of life and access to treatment. 
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Istat tables provided demographic data about the entire 
resident population in the Terni Province (http://demo.
istat.it/). Using these data the prevalence and incidence 
of celiac disease in the province could be calculated for 
the years 2002 through 2010.
Prevalence and incidence are expressed, as the respec-
tive numbers of total cases and news cases within a spec-
ified time period divided by the size of the population at 
risk per 100,000.
Results
In 2010, the Terni Province of Umbria had 330 patients 
(75 males, 255 females) with celiac disease. Table I re-
ports the number of cases, gender and 5-year stratifica-
tion for age at diagnosis. 
Consistent with data from international reports, the 
prevalence of celiac disease was higher in females than 
in males, and it increased constantly over the 2002–2010 
study timeframe (Tab. II, Fig. 1). Prevalence increased 
more markedly in the male population (+18.85) than in 
Tab. I. number of celiac disease cases in umbria (referral area, asl4) in 2002–2010 according to gender (5-yr intervals of diagnosis).
5-yr 
intervals of 
diagnosis
Diagnosis Year
2002 2003 2004 2005 2006 2007 2008 2009 2010
F
e
m
al
e
s
00-04 1 1 3 2 2 5 2
05-09 3 1 1 1 4 2 1 5 3
10-14 10 2 1 2 1 4 3 1
15-19 3 2 1 1 1 4
20-24 2 1 1 5 2 1 1 1 1
25-29 4 2 3 3 5 2 3 2
30-34 3 3 1 5 2 4 4 2  
35-39 6 1 5 4 4 5 4 2 8
40-44 3 2 6 6 4 6 2 7
45-49 1 2 1 3 3 3 2 1 2
50-54 1 1 1 1 3
55-59 2 1 1 1 1 1  
60-64 1 1 1 3  
65-69 1 1 1  
70-74  1 1  
75-79  1  
total 41 16 22 33 29 25 28 28 33
M
al
e
s
00-04 2 1 1 3 3 3
05-09 1 2 2 3 2 3  
0-14 2 1 2 2 1  
15-19 2 3 1 1  
20-24  1 1 1  
25-29  2 1  
30-34  1 1 1 1  
35-39  1 1 2  
40-44 1 1 1 2 2 1 1 1
45-49  1  
50-54  1 1  
55-59   
60-64  2 2  
65-69  1  
70-74  1
75-79  1  
total 8 8 9 10 10 4 13 8 5
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the female (+5.83). Consequently prevalence of celiac 
disease was 4.7-fold higher in females in 2002 and 3.11-
fold higher in 2010. 
Annual incidence oscillated in both males and females, 
tending to stabilize in both sexes in later years. The 
number of new cases was increasingly higher in females 
on a per-year basis (Tab. III, Fig. 2) 
Analysing the incidence in 5-year age groups over the 
2002-2010 period showed that the highest number of 
new cases in males occurred in the first 10 years of life. 
Rates gradually dropped until 35 years of age and then 
rose again in the 40-44 age group. Incidence was low-
est in the 60-64 age group (Tab. IV, Fig. 3). In females, 
the incidence was always greater than in males in each 
5-year age group, reaching maximum peaks in the 10-
14, 25-29, and 35-45 stratification groups. 
Gender-specific differences in incidence were least in 
the 00-04, 05-09 and 15-19 age groups.
Discussion 
Knowing what impact a disease has on the general pop-
ulation enables physicians and healthcare professionals 
to plan and organise effective therapeutic interventions 
and manage their human and material resources to best 
advantage. Patients receive the treatment they need and 
their right to health is safeguarded.
Since celiac disease can no longer be considered as a 
rare pathology of the children, the present study was de-
signed to profile its epidemiology as recorded by Health 
Board No 4 in order to determine whether prevalence 
and incidence had changed over the years in the prov-
ince of Terni, as in the rest of Italy.
We found that prevalence increased constantly between 
2002 and 2010. In contrast, though incidence oscillated 
slightly, it tended to remain constant over time. These 
data confirm that early diagnosis together with life style 
changes by the patient involving a gluten-free diet en-
sure that celiac-related complications, such as gastroin-
testinal cancer and intestinal lymphoma, are avoided and 
life expectancy equals that of the general population.
That prevalence and incidence are greater in women is 
consistent with the general pattern of celiac disease dis-
tribution. In fact, the M:F ratio is reported to be as high 
as 1:2. The 5-year age at diagnosis stratification shows 
that the majority of patients were young adults when ce-
liac disease was diagnosed, as only 63 were less than 
10 years of age at the time of diagnosis. The number 
of diagnoses peaked in the 10-14, 35-40, and 55-60 age 
groups, confirming that the disease was distributed uni-
formly across the entire general population and high-
lighting the need to rectify the assumption that celiac 
disease is a rare disease. 
The present results are in line with regional and national 
trends of celiac disease [9]. Indeed, in the past 10 years, 
Tab. II. prevalence in celiac disease according to gender groups in 
umbria (referral area, asl4) years 2002-2010.
Years Females Males
2002 36.25 7.66
2003 50.10 15.22
2004 68.09 23.37
2005 96.01 32.55
2006 120.34 41.64
2007 141.44 45.26
2008 163.14 56.68
2009 185.05 63.52
2010 211.30 67.77
Fig. 1. prevalence in celiac disease in umbria (referral area, asl4)
years 2002-2010.
Tab. III. incidence in celiac disease according to gender groups in 
umbria (referral area, asl4).
Years 2002–2010
Years Females Males
2002 36.25 7.66
2003 14.06 7.61
2004 18.96 8.41
2005 28.29 9.30
2006 24.75 9.25
2007 21.30 3.69
2008 23.55 11.88
2009 23.34 7.26
2010 27.35 4.52
Fig. 2. incidence of celiac disease (referral area, asl4).
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age at diagnosis has risen in Terni and in the Region of 
Umbria as a whole. The prevalence of celiac disease is at 
present estimated to be around 1% in adults and children 
according to the Italian Ministry of Health Report for the 
year 2009. Patients with celiac disease should amount 
to 2,325 in the Terni population, as this population was 
232,540 in 2010 [9]. However, only 330 were actually 
diagnosed as of 2010. (Those patients were identified as 
meeting the stringent biochemical and histologic criteria 
needed to obtain nearly free medications.) This figure is 
considerably less than the expected 1%. Missing or de-
layed diagnoses might be due to the multiplicity of clini-
cal manifestations of the disease at onset, considering 
that early symptoms may be limited to sites other than 
the gastrointestinal tract, and they may involve the skin, 
or may be gynecologic or autoimmune in nature. 
The use of the public registries of patients with celiac dis-
ease is an efficient and direct way to estimate incidence/
prevalence of the disease. However, it is well known that 
this approach may generate an underestimation of real 
cases, e.g., because of the loss of subjects that may not 
benefit of the exemption (because they are not aware or 
refuse this possibility) or for delays in registration, or be-
cause of changes of residence. This possible bias might 
contribute to the severe loss of diagnoses in Terni.
Nevertheless, we feel that diagnostic criteria need to 
be revised. Only by establishing universally accepted, 
clearly valid criteria can we increase the number of early 
diagnoses, which are essential if we are to offer patients 
best care, quality of life, and survival. 
Finally, finding so many cases of celiac disease in the 
Province of Terni and the rest of Italy suggests that health 
services for patients need to be optimized. Today, for ex-
ample, more than in the past, many patients are adults and 
have the right to employment safeguards. One step in the 
right direction would be to establish a network of specifi-
cally oriented canteens offering appropriate foods.
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Tab. IV. incidence of celiac disease according to age groups in um-
bria (referral area, asl4).
Years 2002-2010
Diagnosis age Females Males
00-04 376.84 287.20
05-09 502.62 289.54
10-14 559.43 177.02
15-19 266.25 147.06
20-24 288.77 54.73
25-29 363.35 44.47
30-34 299.63 50.10
35-39 453.83 46.81
40-44 429.73 120.91
45-49 230.74 13.39
50-54 90.60 27.69
55-59 89.30 0.00
60-64 78.58 56.12
65-69 40.08 14.76
70-74 27.43 16.69
75-79 14.39 19.93
Fig. 3. incidence in celiac disease according to age groups in um-
bria (referral area, asl4) years 2002-2010. 
